Retinoid binding in normal and neoplastic mammary tissue.
The inhibitory effect of dietary supplementation of certain retinoids on mammary carcinogenesis in the rat has been reported from our laboratory. Specific cytosolic retinoic acid binding proteins (cRABP) as well as retinol binding proteins sedimenting as 2S components have been detected in the mammary tissue during normal and neoplastic differentiation. Relatively higher levels of cRABP were observed in the mammary glands from pregnant animals as well as in ovarian hormone independent tumors; whereas in glands obtained from lactating rats and in hormone dependent tumors, lower levels of cRABP were evident. Exogenous treatment of such animals with estradiol-17 beta enhanced the levels of cRABP. The results indicate a possible correlation between endocrine and retinoid function in both normal and neoplastic differentiation of mammary tissue. [3H]retinoic acid-RABP complex, under appropriate conditions, translocates into th nucleus. Unbound [3H]retinoic acid, however, failed to associate with the nuclear sites. Additional studies indicate a possible selective inhibition of ovarian hormones independent tumors by the retinoids.
D000818:Animals; D002467:Cell Nucleus / Q000378:metabolism; D005260:Female; D008321:Mammary Glands, Animal / Q000378:metabolism*; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism*; D009376:Neoplasms, Hormone-Dependent / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012177:Retinol-Binding Proteins / Q000032:analysis / Q000378:metabolism*; D014212:Tretinoin / Q000378:metabolism; D014801:Vitamin A / Q000378:metabolism* / Q000627:therapeutic use
D012177:Retinol-Binding Proteins; D014801:Vitamin A; D014212:Tretinoin